Error: Could not add to watchlist. X
+ Watchlist

Dyax Corp

DYAX:US
Acquired
DYAX:US was acquired by SHP:LN
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.21
Market Cap (USD)
-
Shares Outstanding (m)
147.185
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.21%
% Price Change
-0.28%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Dyax Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology. The Company currently has two recombinant proteins, DX-88 and DX-890 in phase II clinical trials.
Address
55 Network Drive
Burlington, MA 01803
United States
Phone
1-617-225-2500
Show More